Vedana Therapeutics
Develops next-generation therapies for migraine prevention
$46MSeries A
Role not disclosedActivity from announced rounds
Develops next-generation therapies for migraine prevention
Develops first- and best-in-class antibody-drug conjugates (ADCs) for cancer treatment